Print

Professor C. Scott Hemphill Testifies On the Role of Incentives in Health Care

Hemphill, an Expert in Antitrust, Intellectual Property, and the Regulation of Industry, Appears at Hearing of Energy and Commerce Committee

Media Contact: Public Affairs, 212-854-2650 or publicaffairs@law.columbia.edu

New York, June 11, 2014—Columbia Law School Professor C. Scott Hemphill, who teaches about the law and economics of innovation and competition, testified today in Washington, D.C. at a subcommittee hearing of the U.S. House of Representatives’ Energy and Commerce Committee.

At the hearing, “21st Century Cures: Examining the Role of Incentives in Advancing Treatments and Cures for Patients,” Hemphill spoke about the role of patent protection and regulation in pharmaceutical innovation. He called for a careful study of the so-called "lost innovation problem"—the idea that drug makers are not developing new medicines because of insufficient incentives—so that any solution to the problem can be narrowly targeted.
 
"Claims that larger drug maker rewards would increase innovation are easy to make, but hard to pin down," he testified.
 

 

# # #

Columbia Law School, founded in 1858, stands at the forefront of legal education and of the law in a global society. Columbia Law School combines traditional strengths in corporate law and financial regulation, international and comparative law, property, contracts, constitutional law, and administrative law with pioneering work in intellectual property, digital technology, tax law and policy, national security, human rights, sexuality and gender, and environmental law.

Join us on Facebook
Follow us on Twitter: www.twitter.com/columbialaw